Management of maxillofacial aneurysmal bone cysts: a single center experience.

PURPOSE: The aim of the present study was to describe our institutional experience in the management of aneurysmal bone cysts of the maxillofacial region.

METHODS

This was a retrospective case series conducted at a tertiary care center. The study included seven patients diagnosed with ABC of the maxillofacial bones. Lesion locations included the maxilla (n = 3), mandible (n = 2), frontal bone (n = 1), and sphenoid bone (n = 1). Surgical resection was done in 4 patients while sclerotherapy was performed in 3.

RESULTS

The follow-up period ranged from 11 to 71 months. No recurrences were observed after surgical excision. Patients treated with sclerotherapy exhibited marked reduction in lesion size with stable imaging findings, and none required further injections or demonstrated lesion regrowth.

CONCLUSIONS

Aneurysmal bone cysts of the maxillofacial bones, though rare, should be included in the differential diagnosis of skull lesions, particularly in young patients. Complete surgical resection remains the preferred treatment when feasible. However, in cases where surgery carries significant morbidity or is anatomically impractical, sclerotherapy represents a valuable and safe alternative.